Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging

NCT06148233 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06148233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06148233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CSF1R PET Probe [18F]CSF-23 in Alzheimer's Disease Brain Imaging
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 15, 2023
Completion date
September 14, 2024
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, neurodegenerative diseases, positron emission tomography